Cellectis (CLLS) Gross Margin (2015 - 2023)

Cellectis (CLLS) recorded quarterly Gross Margin of 40.99% in Q4 2023, up 344.36% quarter-over-quarter from 16.77% in Q3 2023, and up 4073.0% on a YoY basis from 0.98% in Q4 2022.

Cellectis (CLLS) Gross Margin (2015 - 2023) Analysis & Trends

Cellectis' Gross Margin history runs 9 years deep, the most recent figure standing at 40.99% for Q4 2023.

  • In Q4 2023, Gross Margin rose 4073.0% year-over-year to 40.99%; the TTM figure through Dec 2023 stood at 2.38% (down 210.0% YoY), while the FY2025 annual figure was 100.0%, changed 0.0% from the prior year.
  • Gross Margin was 40.99% for Q4 2023 at Cellectis, up from 16.77% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 90.82% in Q1 2020 to a low of 140.29% in Q1 2023.
  • Historically, Gross Margin has averaged 3.33% across 5 years, with a median of 2.88% in 2021.
  • The sharpest annual moves came in 2021 and 2023: Gross Margin jumped 9576 bps in 2021, then sank 14221 bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 27.79% in 2019, then jumped by 31 bps to 19.27% in 2020, then soared by 97 bps to 0.59% in 2021, then jumped by 144 bps to 0.26% in 2022, then soared by 15538 bps to 40.99% in 2023.
  • The last three Gross Margin figures came in at 40.99% (Q4 2023), 16.77% (Q3 2023), and 69.1% (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Cellectis 17.40 Bn 17.21 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 40.99%
Sep 30, 2023 -16.77%
Jun 30, 2023 69.10%
Mar 31, 2023 -140.29%
Dec 31, 2022 0.26%
Sep 30, 2022 -109.71%
Jun 30, 2022 74.83%
Mar 31, 2022 1.92%
Dec 31, 2021 -0.59%
Sep 30, 2021 -10.84%
Jun 30, 2021 -5.17%
Mar 31, 2021 -9.15%
Dec 31, 2020 -19.27%
Sep 30, 2020 -26.56%
Jun 30, 2020 -100.93%
Mar 31, 2020 90.82%
Dec 31, 2019 -27.79%
Sep 30, 2019 49.85%
Jun 30, 2019 29.25%
Mar 31, 2019 43.44%